SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9478	Companies
185482	Keywords
117825	Articles
99322	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 09/27/2024 at 13:05, 1 year 2 months ago

Dupixent Authorized in China as First Biologic Medicine for COPD Patients

China Approval COPD Dupixent Biologic Medicine
PRESS RELEASE

published on 09/27/2024 at 13:00, 1 year 2 months ago

Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
Dupixent approved in China as the first-ever biologic medicine for COPD patients, following landmark phase 3 studies. Approval crucial for addressing COPD burden in China

China COPD Dupixent Biologic Medicine Phase 3 Studies
BRIEF

published on 09/21/2024 at 00:41, 1 year 2 months ago

Sarclisa Approved in the United States for the Treatment of Multiple Myeloma

FDA Sanofi Multiple Myeloma Sarclisa First Line Treatment
BRIEF

published on 09/20/2024 at 13:50, 1 year 2 months ago

CHMP recommends approval of Dupixent for children aged 12 months and older

Children Medicine Dupixent CHMP Esophagitis
PRESS RELEASE

published on 09/20/2024 at 13:45, 1 year 2 months ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old based on positive phase 3 study results. Dupixent would be the first medicine indicated for EoE in this age group

Children Dupixent CHMP EU Approval Eosinophilic Esophagitis
BRIEF

published on 09/20/2024 at 11:35, 1 year 2 months ago

Sanofi's Tolebrutinib Shows Promise in Delaying Disability Progression in MS

Multiple Sclerosis ECTRIMS 2024 Tolebrutinib HERCULES Study Disability Progression
PRESS RELEASE

published on 09/20/2024 at 11:30, 1 year 2 months ago

Press Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study
Study shows tolebrutinib delays disability progression in non-relapsing secondary progressive MS by 31%; global regulatory submissions in H2 2024. ECTRIMS 2024 data presented

ECTRIMS 2024 Tolebrutinib Disability Progression Secondary Progressive MS Global Regulatory Submissions
BRIEF

published on 09/16/2024 at 18:49, 1 year 2 months ago

Sanofi Reports Share and Voting Rights Data for August 2024

Voting Rights Shares Investor Relations Sanofi August 2024
PRESS RELEASE

published on 09/16/2024 at 18:44, 1 year 2 months ago

Sanofi: Information concerning the total number of voting rights and shares - August 2024
Sanofi discloses total number of voting rights and shares as per French Commercial Code and AMF regulations

Voting Rights French Commercial Code Shares AMF Regulations Sanofi
BRIEF

published on 09/11/2024 at 07:10, 1 year 2 months ago

Dupixent Phase 3 Study Shows Promise for CSU Patients

Sanofi Phase 3 Dupixent CSU Regeneron

Accesswire

Published on 12/05/2025 at 15:25, 13 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 38 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 38 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 38 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 13 hours 3 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:05, 33 minutes ago

Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 16 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 21 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 28 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 53 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings

Les Echos

Published on 12/05/2025 at 15:10, 27 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 6 hours 53 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 21 hours 38 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 53 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 54 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

View all LES ECHOS COMFI WIRE